A Phase 1, Open-Label Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Atorvastatin
Phase of Trial: Phase I
Latest Information Update: 01 Jan 2017
At a glance
- Drugs Isavuconazonium (Primary) ; Atorvastatin
- Indications Aspergillosis; Candidiasis; Zygomycosis
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 13 Sep 2013 Results presented at the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy.
- 30 Aug 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Aug 2012 Actual initiation date (Aug 2012) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History